The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital


Associate Professor Aeron Hurt

Associate Professor Aeron Hurt

Associate Professor Aeron Hurt

(03) 9342 9314 | [email protected]

Head Virologist
Public Health
Victorian Infectious Diseases Reference Laboratory (VIDRL), WHO Collaborating Centre for Reference and Research on Influenza
Lab Group(s):
Hurt Group

Associate Professor Aeron Hurt is the Deputy Director (Acting) of the WHO Collaborating Centre for Reference and Research on Influenza and heads the Antiviral Susceptibility Analysis Surveillance Unit and Research group. Aeron is a world leader in influenza antiviral research and regularly acts as an external Temporary Advisor to the WHO. He has completed a number of short-term consultancies for the Vietnamese Ministry of Health, the WHO, and the Australian Government related to influenza surveillance, epidemiology and laboratory analysis. Aeron is on the Editorial board of the journals Antiviral Research, Virology Journal and Infection, Ecology and Epidemiology. Aeron completed a PhD in influenza virology at Monash University and holds an honorary Principal Fellow appointment with the University of Melbourne.

  • Key Achievements
    • Aeron has published over 100 peer-reviewed research and review papers, predominately in the field of influenza including articles in Science, Nature, New England Journal of Medicine, Nature Medicine and Lancet Infectious Diseases. Aeron has achieved over $2.5 million in external research funding through NHMRC grants, most recently for a combined NHMRC-ASTAR (Singapore) award to look at the effectiveness of antiviral drugs against resistant influenza viruses in animal models.

    Loading ORCID data...
    • Investigating the relationship between antiviral clinical effectiveness and in vitro sensitivity

      Aeron’s group has established a detailed and sensitive ferret influenza infection/antiviral treatment model that monitors virological, immunological and behavioural components to assess antiviral effectiveness pre or post influenza viral infection. Using the model they can help establish an important understanding of clinical effectiveness against viruses with reduced antiviral sensitivity.

    Research Groups
    • Hurt Group

      Aeron’s research team at the WHO Collaborating Centre for Reference and Research on Influenza works on aspects of understanding the replication and transmission of drug resistant influenza viruses, characterising novel drug resistance mutations, and the global movement and evolution of human and avian influenza viruses.

      Lab Team

      Hurt Group

Full University of Melbourne profile